HER2-targeted antibody drug conjugates for ovarian cancer therapy.
Jiang J, Dong L, Wang L, Wang L, Zhang J, Chen F, Zhang X, Huang M, Li S, Ma W, Xu Q, Huang C, Fang J, Wang C.
Jiang J, et al.
Eur J Pharm Sci. 2016 Oct 10;93:274-86. doi: 10.1016/j.ejps.2016.08.015. Epub 2016 Aug 7.
Eur J Pharm Sci. 2016.
PMID: 27509865